Baxter International | BAX - Stock


Baxter International reported $2.32B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 97.99M 5.57M Mar/2026
AtriCure USD 81.14M 2.65M Mar/2026
Avanos Medical USD 141.3M 6.7M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Cooper Companies USD 876.4M 30.4M Dec/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Fresenius EUR 2.61B 19M Dec/2025
Globus Medical USD 772.6M 13.32M Mar/2026
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
ICU Medical USD 605.59M 10.27M Mar/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
J&J USD 14.58B 392M Mar/2026
Laboratory Of America USD 497.7M 37M Mar/2026
Masimo USD 400M 61.4M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Merit Medical Systems USD 352.39M 18.68M Mar/2026
Quest Diagnostics USD 225M 36M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
Terumo JPY 311.91B 10.92B Sep/2025
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026